Author

Pal Miheller 1

1 Semmelweis Egyetem,Bu

BIOSIMILAR INFLIXIMAB: EFFICACY AND SAFETY BASED ON INTERIM RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Klaudia Farkas, Barbara Dorottya Lovasz, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Tünde Kristóf, Peter L Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamás Szamosi, Zoltan Gabor Szepes, Gábor Tamás Tóth, Aron Vincze;;

BODY COMPOSITION AS A PREDICTOR FACTOR OF DISEASE OUTCOME IN INFLAMMATORY BOWEL DISEASE – RESULTS OF 3-YEAR FOLLOW UP

Agnes Anna Csontos, Andrea Molnár, Rita Hencz, Dóra Piri, Sarolta Dakó, Tamás Ferenci, Erzsébet Pálfi, Pal Miheller

CHANGES OF ADALIMUMAB TROUGH LEVELS CORRELATE WITH BODY COMPOSITION PARAMETERS

Agnes Anna Csontos, Andrea Molnár, Zsolt Piri, Balázs Katona, Klaudia Farkas, Tamás Molnár, Pal Miheller

CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY

Lorant Gonczi, Kata Szántó, Klaudia Farkas, Tamás Molnár, Tamás Szamosi, Eszter Schäfer, Petra Anna Golovics, Barbara Dorottya Lovasz, Mark Juhasz, Árpád V. Patai, Aron Vincze, Patrícia Sarlós, Karoly Palatka, Alexandra Farkas, Gábor Tamás Tóth, Peter L Lakatos, Pal Miheller, Ákos Iliás

COBITOLIMOD FOR MODERATE-TO-SEVERE LEFT-SIDED ULCERATIVE COLITIS (CONDUCT): A PHASE IIB, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL

Raja Atreya, Laurent Peyrin–Biroulet, Andrii Klymenko, Monica Augustyn, Igor Bakulin, Dusan Slankamenac, Pal Miheller, Antonio Gasbarrini, Xavier Hebuterne, Karin Arnesson, Thomas Knittel, Jan Kowalski, Markus F. Neurath, William Sandborn, Walter Reinisch

COMPREHENSIVE DNA METHYLATION ANALYSIS REVEALS A COMMON TEN-GENE METHYLATION SIGNATURE IN COLORECTAL ADENOMAS AND CARCINOMAS

Árpád V. Patai, Gabor Valcz, Alexandra Kalmár, Peter Hollosi, Bálint Péterfia, Árpád V. Patai, Barnabas Wichmann, Ferenc Sipos, Pal Miheller, Zsolt Tulassay, Bela Molnar

DIFFERENTIATION BETWEEN PANCREATIC CYSTIC LESIONS USING IMAGE PROCESSING SOFTWARE ON ENDOSCOPIC-ULTRASONOGRAPHIC (EUS) IMAGES

Bánk Keczer, Pal Miheller, Miklós Horváth, Ákos Szűcs, Tamás Marjai, László Harsányi, Attila Szíjártó, István Hritz

EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Barbara Dorottya Lovasz, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Lilla Laura Lakner, Árpád V. Patai, Ágnes Szabone Salamon;;

EFFICACY OF VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH SEVERE, THERAPEUTIC RESISTANT INFLAMMATORY BOWEL DISEASE

Renáta Bor, Klaudia Farkas, Pal Miheller, Karoly Palatka, Tamás Szamosi, Peter L Lakatos, Krisztina Barbara Gecse, Petra Anna Golovics, Aron Vincze, Lilla Lakner, Mariann Rutka, Anita Balint, Anna Fabian, Ágnes Milassin, Zoltan Gabor Szepes, Tamás Molnár

FINAL RESULTS ON EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra Anna Golovics, Barbara Dorottya Lovasz, Lorant Gonczi, János Banai, László Bene, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamá

Item 1 - 10 / 47
1
2 3 4 5